1. Korean Liver Cancer Association (KLCA), National Cancer Center (NCC) Korea. 2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma. J Liver Cancer. 2023; 23:1–120.
2. Singal AG, Llovet JM, Yarchoan M, Mehta N, Heimbach JK, Dawson LA, et al. AASLD practice guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma. Hepatology. 2023; 78:1922–1965.
Article
3. European Association for the Study of the Liver. EASL clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2018; 69:182–236.
5. Kim DH, Choi SH, Park SH, Kim KW, Byun JH, Kim SY, et al. Liver imaging reporting and data system category M: a systematic review and meta-analysis. Liver Int. 2020; 40:1477–1487.
Article
6. Shin J, Lee S, Hwang JA, Lee JE, Chung YE, Choi JY, et al. MRI-diagnosis of category LR-M observations in the liver imaging reporting and data system v2018: a systematic review and meta-analysis. Eur Radiol. 2022; 32:3319–3326.
7. Kim DH, Choi SH. Inter-reader agreement for CT/MRI LI-RADS category M imaging features: a systematic review and meta-analysis. J Liver Cancer. 2024; Apr. 15. doi: 10.17998/jlc.2024.04.05 [Epub ahead of print].
Article
8. Kang JH, Choi SH, Lee JS, Park SH, Kim KW, Kim SY, et al. Interreader agreement of liver imaging reporting and data system on MRI: a systematic review and meta-analysis. J Magn Reson Imaging. 2020; 52:795–804.
Article
9. Jeong WK, Jamshidi N, Felker ER, Raman SS, Lu DS. Radiomics and radiogenomics of primary liver cancers. Clin Mol Hepatol. 2019; 25:21–29.
Article